@article{28e12a900fca4f9aa1e2f947071f6af6,
title = "When is the right time to discuss ECMO?",
author = "Feldman, {William B.} and Keller, {Steven P.}",
note = "Funding Information: WBF receives funding from the National Institutes of Health (NIH) training grant 5T32HL007633-34 and consults for the non-profit organisation Alosa Health. SPK receives funding from the NIH 1K08HL143342-01 and serves on the Critical Care Advisory Board of Abiomed, the Scientific Advisory Board of Paragonix Technologies, and consults for X-COR Therapeutics. Funding Information: WBF receives funding from the National Institutes of Health (NIH) training grant 5T32HL007633-34 and consults for the non-profit organisation Alosa Health. SPK receives funding from the NIH 1K08HL143342-01 and serves on the Critical Care Advisory Board of Abiomed, the Scientific Advisory Board of Paragonix Technologies, and consults for X-COR Therapeutics. ",
year = "2019",
month = nov,
doi = "10.1016/S2213-2600(19)30278-4",
language = "English (US)",
volume = "7",
pages = "939--940",
journal = "The Lancet Respiratory Medicine",
issn = "2213-2600",
publisher = "Elsevier Limited",
number = "11",
}